Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2026-09-15 16:00:31 ET · period of report 2026-09-11 · accession 0001683168-26-007158 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 16:00 | 2026-09-11 | PHIO | Carson Lisa Cabott | CFO | F - Tax | $1.03 | -12.9K | 81.1K | -14% | -$13.3K |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.0001 par value | 2026-09-11 | F | D | 12,888 | $1.03 | 81,112 | D | — | — | (F1) The transaction represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold. (F2) Includes shares of common stock underlying unvested restricted stock units. |